SG11201602661PA - Novel peptide compositions - Google Patents
Novel peptide compositionsInfo
- Publication number
- SG11201602661PA SG11201602661PA SG11201602661PA SG11201602661PA SG11201602661PA SG 11201602661P A SG11201602661P A SG 11201602661PA SG 11201602661P A SG11201602661P A SG 11201602661PA SG 11201602661P A SG11201602661P A SG 11201602661PA SG 11201602661P A SG11201602661P A SG 11201602661PA
- Authority
- SG
- Singapore
- Prior art keywords
- novel peptide
- peptide compositions
- compositions
- novel
- peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361890056P | 2013-10-11 | 2013-10-11 | |
| US201461940095P | 2014-02-14 | 2014-02-14 | |
| PCT/US2014/058646 WO2015054006A2 (en) | 2013-10-11 | 2014-10-01 | Novel peptide compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201602661PA true SG11201602661PA (en) | 2016-05-30 |
Family
ID=52813728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201602661PA SG11201602661PA (en) | 2013-10-11 | 2014-10-01 | Novel peptide compositions |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP3054967A4 (en) |
| JP (1) | JP2017501967A (en) |
| KR (1) | KR20160065969A (en) |
| CN (1) | CN105828831A (en) |
| AU (1) | AU2014332346B2 (en) |
| BR (1) | BR112016007816A2 (en) |
| CA (1) | CA2926641A1 (en) |
| CL (1) | CL2016000836A1 (en) |
| IL (1) | IL244956B (en) |
| MX (1) | MX2016004660A (en) |
| RU (1) | RU2016112931A (en) |
| SG (1) | SG11201602661PA (en) |
| WO (1) | WO2015054006A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017150327A1 (en) * | 2016-03-03 | 2017-09-08 | 不二製油グループ本社株式会社 | Food additive composition for promoting in-brain secretion of neurotrophins |
| MX2019009627A (en) * | 2017-02-16 | 2019-12-11 | Caregen Co Ltd | Conjugate of salicylic acid and peptide. |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4244946A (en) | 1979-06-11 | 1981-01-13 | The Salk Institute For Biological Studies | Water-soluble peptides affecting gonadal function |
| US4305872A (en) | 1979-10-19 | 1981-12-15 | Kenneth Wingrove | Polypeptide derivatives |
| US4316891A (en) | 1980-06-14 | 1982-02-23 | The Salk Institute For Biological Studies | Extended N-terminal somatostatin |
| US20020168761A1 (en) | 2000-01-24 | 2002-11-14 | Gour Barbara J. | Peptidomimetic modulators of cell adhesion |
| JP2001500475A (en) | 1996-07-12 | 2001-01-16 | マクギル ユニバーシティ | Compounds and methods for modulating cell adhesion |
| US7563862B2 (en) | 2001-08-24 | 2009-07-21 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and methods for their use in treatment of brain damage |
| WO2003018754A2 (en) * | 2001-08-24 | 2003-03-06 | Neuronz Limited | Neural regeneration peptide and methods for their use in treatment of brain damage |
| AU2003293807A1 (en) * | 2002-12-24 | 2004-07-22 | Algonomics N.V. | Mhc class i restricted t-cell stimulating peptides from hepatitis b virus |
| WO2005042561A2 (en) * | 2003-10-31 | 2005-05-12 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and methods of use |
| WO2007011595A2 (en) | 2005-07-15 | 2007-01-25 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and antioxidants protect neurons from degeneration |
| WO2012006598A2 (en) * | 2010-07-09 | 2012-01-12 | Dana-Farber Cancer Institute, Inc. | Stabilized insulinotropic peptides and methods of use |
| KR20140140546A (en) * | 2012-02-10 | 2014-12-09 | 타릭스 파마슈티컬스 엘티디. | Compositions and methods for treatment of peripheral vascular disease |
-
2014
- 2014-10-01 BR BR112016007816A patent/BR112016007816A2/en not_active Application Discontinuation
- 2014-10-01 CA CA2926641A patent/CA2926641A1/en not_active Abandoned
- 2014-10-01 MX MX2016004660A patent/MX2016004660A/en unknown
- 2014-10-01 EP EP14852391.3A patent/EP3054967A4/en not_active Withdrawn
- 2014-10-01 WO PCT/US2014/058646 patent/WO2015054006A2/en active Application Filing
- 2014-10-01 KR KR1020167011913A patent/KR20160065969A/en not_active Application Discontinuation
- 2014-10-01 CN CN201480066852.9A patent/CN105828831A/en active Pending
- 2014-10-01 SG SG11201602661PA patent/SG11201602661PA/en unknown
- 2014-10-01 JP JP2016521985A patent/JP2017501967A/en active Pending
- 2014-10-01 RU RU2016112931A patent/RU2016112931A/en not_active Application Discontinuation
- 2014-10-01 AU AU2014332346A patent/AU2014332346B2/en not_active Ceased
-
2016
- 2016-04-06 IL IL24495616A patent/IL244956B/en not_active IP Right Cessation
- 2016-04-11 CL CL2016000836A patent/CL2016000836A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017501967A (en) | 2017-01-19 |
| KR20160065969A (en) | 2016-06-09 |
| WO2015054006A2 (en) | 2015-04-16 |
| IL244956B (en) | 2019-10-31 |
| AU2014332346A1 (en) | 2016-05-05 |
| AU2014332346B2 (en) | 2019-01-24 |
| CN105828831A (en) | 2016-08-03 |
| IL244956A0 (en) | 2016-05-31 |
| RU2016112931A (en) | 2017-11-16 |
| EP3054967A2 (en) | 2016-08-17 |
| RU2016112931A3 (en) | 2018-06-20 |
| MX2016004660A (en) | 2016-11-14 |
| CA2926641A1 (en) | 2015-04-16 |
| BR112016007816A2 (en) | 2017-12-05 |
| WO2015054006A3 (en) | 2015-06-04 |
| EP3054967A4 (en) | 2017-04-19 |
| CL2016000836A1 (en) | 2016-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1216757A1 (en) | Peptide compound | |
| SG11201602596UA (en) | Stabilized efinaconazole compositions | |
| GB201304662D0 (en) | Compositions | |
| ZA201505966B (en) | Peptides and compositions | |
| HK1220697A1 (en) | Peptide compositions | |
| GB201303771D0 (en) | Nanoparticles peptide compositions | |
| GB201608461D0 (en) | Compositions | |
| GB201317105D0 (en) | Novel Composition | |
| HUE050164T2 (en) | Novel four-ctl epitope-joined peptide | |
| HK1216715A1 (en) | Novel hemoglobin-derived peptide based pharmaceutical compositions | |
| HK1211596A1 (en) | Peptide | |
| GB201316463D0 (en) | Novel compositions | |
| HK1211595A1 (en) | Peptide | |
| ZA201505650B (en) | New compositions | |
| HK1198769A1 (en) | Novel peptide | |
| GB201319923D0 (en) | Novel composition | |
| GB201310513D0 (en) | Novel composition | |
| IL244956B (en) | Novel peptide compositions | |
| GB201320962D0 (en) | Compositions | |
| GB201303787D0 (en) | Nanoparticle peptide compositions | |
| GB201320959D0 (en) | Compositions | |
| GB201316464D0 (en) | Novel compositions | |
| GB201315598D0 (en) | Novel compositions | |
| GB201312224D0 (en) | Compositions | |
| GB201322510D0 (en) | Novel composition |